Doctor profile · Federal record

Dr. Narotham Thudi, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Irving, TX

  • NPI 1861401788
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 33 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2021 N Macarthur Blvd, Suite 400
Irving, TX 750612219
(972) 256-3537
fax (972) 255-7916
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
December 11, 2012
Year of graduation
1993 — 33 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Texas #L9930
Medicaid (2)
TX #194493601 · TX #194493602

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1861401788. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
66,742
Distinct HCPCS
10
Medicare allowed
$225,495
HCPCS Description Services Patients Avg allowed
Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram 22,620 13 $0
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 22,440 21 $0
J1756 Injection, iron sucrose, 1 mg 14,000 20 $0
36415 Insertion of needle into vein for collection of blood sample 1,127 316 $8
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,054 310 $8
80053 Blood test, comprehensive group of blood chemicals 1,022 308 $10
99213 Established patient office or other outpatient visit, 20-29 minutes 1,010 306 $90
J1100 Injection, dexamethasone sodium phosphate, 1 mg 954 23 $0
J3489 Injection, zoledronic acid, 1 mg 191 26 $8
83615 Lactate dehydrogenase (enzyme) level 184 107 $6

In context: peer comparison

Among 2 peers in Irving Hematology & Oncology Physician, average services per provider: 1,463. This provider delivers 46× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,384
Transactions
26
Manufacturers
11
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 13 $1,186.42
AstraZeneca Pharmaceuticals Lp 3 $940.45
Merck Sharp & Dohme LLC 2 $43.43
Adaptive Biotechnologies Corporation 1 $33.93
Regeneron Healthcare Solutions, INC. 1 $33.65
Kite Pharma, INC. 1 $31.44
Aveo Pharmaceuticals, INC. 1 $26.27
Pfizer INC. 1 $25.17
Incyte Corporation 1 $24.80
Geron Corporation 1 $23.69
E.R. Squibb & Sons, L.L.C. 1 $15.16

By nature of payment

Long Term Medical Supply or Device Loan
$1,164
Consulting Fee
$910
Food and Beverage
$311

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
885
Patients
271
Total drug cost
$618,016
Drug Type Claims Patients Total cost
Anastrozole Generic 129 32 $3,524
Eliquis (Apixaban) Brand 123 28 $91,375
Dexamethasone Generic 86 32 $676
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 75 29 $2,293
Ondansetron Hcl Generic 72 48 $661
Prochlorperazine Maleate Generic 62 44 $899
Acyclovir Generic 59 0 $1,063
Olanzapine Generic 57 21 $292
Xarelto (Rivaroxaban) Brand 47 0 $39,680
Gabapentin Generic 40 11 $717

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Narotham Thudi's medical specialty?
Dr. Narotham Thudi practices Hematology & Oncology Physician in Irving, TX.
Where does Dr. Narotham Thudi practice?
Dr. Narotham Thudi practices at 2021 N Macarthur Blvd, Irving, TX 750612219. Office phone: 9722563537.
What is Dr. Narotham Thudi's NPI?
Dr. Narotham Thudi's National Provider Identifier (NPI) is 1861401788, issued by NPPES.
Does Dr. Narotham Thudi accept Medicare assignment?
Yes. Dr. Narotham Thudi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Narotham Thudi commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, iron sucrose, 1 mg (HCPCS J1756). Source: CMS Medicare Physician & Other Practitioners file.